1. Introduction {#sec1}
===============

*Flos Chrysanthemi* is a dried capitulum belonging to the Compositae family and is native to Asia and northeastern Europe \[[@B1]--[@B3]\]. There are 7 different varieties of *Flos Chrysanthemi*, namely, Haoju, Chuju, Gongju, Hangju (Dabaiju, Huju, and Xiaobaiju), and Huaiju \[[@B4]\]. As a traditional Chinese medicine and popular herbal tea in China, *Flos Chrysanthemi* is commonly used to dispel wind, reduce heat, calm a hyperactive liver, and improve eyesight \[[@B4], [@B5]\]. Various studies have identified three different types of bioactive compounds in *Flos Chrysanthemi*, namely, flavonoids, caffeic acid, and phenolics, which provide a series of pharmacological actions such as antioxidative activity, anti-inflammatory activity, anticancer activity, lipid-lowering effect in a fatty liver, and antiangiogenic activity \[[@B6]--[@B13]\].

Pharmacokinetics plays an important role in drug development by quantitatively describing various dynamic processes in the body. At present, there are a few pharmacokinetic studies on luteolin, apigenin, diosmetin, and chrysoeriol in oral *Flos Chrysanthemi* extract \[[@B14]--[@B16]\]. The pharmacokinetics of *Flos Chrysanthemi* has not been comprehensively evaluated in the existing studies because its extract contains a wide variety of chemical compounds. Hence, it is of relevance to further research the pharmacokinetics of various ingredients in rat plasma after the oral intake of *Flos Chrysanthemi* extract.

This research develops a sensitive and reliable UPLC-MS/MS method for the determination of thirteen compounds in rat plasma after oral administration of *Flos Chrysanthemi* extract. In addition, this is the first pharmacokinetic study on the chemical components luteolin 7-O-glucuronide and apigenin 7-glucoside. This study would provide reference for further pharmacological studies on *Flos Chrysanthemi* extract.

2. Experimental {#sec2}
===============

2.1. Chemicals, Reagents, and Materials {#sec2.1}
---------------------------------------

Acetonitrile (Thermo Fisher Scientific, Fair Lawn, NJ, USA), methanol (Thermo Fisher Scientific, Fair Lawn, NJ, USA), and formic acid (ROE SCIENTIFIC INC, Newark, USA, MO, USA) were of HPLC grade. Water used in the experiment was purified with Milli-Q advanced ultrapure water system (Millipore, Milford, MA, USA). Luteolin, cynaroside, luteolin 7-O-glucuronide, isochlorogenic acid C, chlorogenic acid, cryptochlorogenic acid, apigenin, apigenin 7-glucoside, acacetin, hyperoside, isoquercitrin, tilianin, hesperidin, and icariin (internal standard (IS)) (purity ≥ 99%) were purchased from Chengdu Must Bio-Technology Co., Ltd. (Chengdu, China).

2.2. Apparatus and Analytical Conditions {#sec2.2}
----------------------------------------

The UPLC-MS/MS system was made up of Agilent 1290 UPLC combined with an Agilent 6470 series triple quadrupole mass spectrometer, and AJS ESI was selected as a source. The chromatographic separation was performed on an ACQUITY UPLC BEH C~18~ (2.1 × 100 mm, 1.7 *μ*m) column, set at 20°C. Mobile phases used were 0.1% (*v*/*v*) formic acid in water (A) and acetonitrile (B). The following elution gradient was used: 0-2 min, 2%-25% B; 2-4 min, 25%-26% B; 4-9 min, 26%-75% B; and 9-10 min, 75%-90% B. The flow rate was maintained at 0.3 mL/min, and a 5 *μ*L sample was injected each time. Quantitative parameters are displayed in [Table 1](#tab1){ref-type="table"}. And the chemical structures of 13 ingredients are shown in [Figure 1](#fig1){ref-type="fig"}.

2.3. The Acquisition of *Flos Chrysanthemi* Extract {#sec2.3}
---------------------------------------------------

To prepare the *Flos Chrysanthemi* extract, 1000 g of *Flos Chrysanthemi* powder was weighed and extracted twice using 14 L of 70% (*v*/*v*) ethanol via reflux for 80 min each time, according to Chinese Pharmacopoeia (2015). The extracted solutions were then filtered, mixed, and evaporated under reduced pressure. The *Flos Chrysanthemi* extract was pressed into powder and stored in a dryer until analysis. The extract contained luteolin, cynaroside, luteolin 7-O-glucuronide, isochlorogenic acid C, chlorogenic acid, cryptochlorogenic acid, apigenin, apigenin 7-glucoside, acacetin, hyperoside, isoquercitrin, tilianin, and hesperidin at 14.00, 17.11, 1.63, 5.18, 3.10, 0.65, 0.70, 3.89, 0.01, 0.01, 0.01, 0.21, and 0.22 mg/g, respectively.

2.4. Stock and Working Solution {#sec2.4}
-------------------------------

Stock solutions of luteolin, cynaroside, luteolin 7-O-glucuronide, isochlorogenic acid C, chlorogenic acid, cryptochlorogenic acid, apigenin, apigenin 7-glucoside, acacetin, hyperoside, isoquercitrin, tilianin, hesperidin, and icariin (internal standard solution) were prepared individually and diluted to 1 mg/mL with methanol. Appropriate amounts of the 13 different stock solutions were added together in methanol for the mixed standard solution. The calibration solutions were prepared by adding 20 *μ*L IS and appropriate volumes of mixed standard solution into 100 *μ*L blank rat plasma. Low, medium, and high concentrations of quality control (QC) samples consisting of appropriate mixed standard solutions and blank plasma sample, adjusted to desired concentrations, were selected as calibration solutions. These solutions were kept at 4°C.

2.5. Sample Preparation {#sec2.5}
-----------------------

20 *μ*L methanol (volume corresponding to that of QC samples and calibration curve) and 20 *μ*L IS (1 *μ*g/mL) were added into 100 *μ*L plasma sample, which was then vortex-mixed with 400 *μ*L acetonitrile for 3 min. The mixed solution was then centrifuged for 10 min at 14,000 rpm. After collecting the supernatant in a clean Eppendorf tube, the supernatant was evaporated to dryness under a gentle stream of nitrogen gas. The residue was dissolved in 100 *μ*L methanol, vortex-mixed for 3 min, and then centrifuged for 10 min at 14,000 rpm. Finally, 5 *μ*L supernatant was used for analysis by the UPLC-MS/MS system.

2.6. Method Validation {#sec2.6}
----------------------

### 2.6.1. Specificity {#sec2.6.1}

Plasma samples acquired at 0.08 h after oral administration of *Flos Chrysanthemi* extract were compared to spiked plasma samples (containing working solutions and IS) and blank plasma samples from six different rats to evaluate method specificity and identify endogenous interfering substances.

### 2.6.2. The Calibration Curves and LLOQ {#sec2.6.2}

Blank rat plasma individually spiked with different concentrations of mixed standard solution and IS was quantitatively measured for three consecutive days, in replica, to validate the linearity. Calibration curves were drawn with peak-area ratios (*y*) of analyte relative to IS against its minimal concentration (*x*). The weighting factor was1/*x*^2^. The lowest limit of quantification (LLOQ) was calculated based on a signal-to-noise ratio of approximately 10 (S/N ≥ 10).

### 2.6.3. Precision and Accuracy {#sec2.6.3}

Intra- and interday precision and accuracy were estimated by analysing six duplicated QC samples at different concentrations as follows: 1, 10, and 200 ng/mL for tilianin and hesperidin; 5, 50, and 1000 ng/mL for isochlorogenic acid C, chlorogenic acid, cryptochlorogenic acid, apigenin, apigenin 7-glucoside, acacetin, hyperoside, and isoquercitrin; 10, 100, and 2000 ng/mL for luteolin 7-O-glucuronide; and 20, 200, and 4000 ng/mL for luteolin and cynaroside. A standard calibration curve was plotted based on the above readings. Intraday and interday precisions were measured by RSD, and accuracy was measured by relative error (RE) of respective readings.

### 2.6.4. The Recovery and Matrix Effect {#sec2.6.4}

Mixed working solution with IS, extracted samples of plasma samples spiked with mixed working solution and IS, and postextraction blank samples (containing IS) spiked with mixed working solution of three QC concentrations were quantitatively analysed in the same assay. Recovery was measured with peak-area differences between the corresponding extraction and postextraction spiked samples. A matrix effect was measured with peak-area differences between the corresponding extraction samples and mixed working solution. Six parallel experiments were performed in total.

### 2.6.5. Stability {#sec2.6.5}

To study the stability of all compounds in rat plasma, low, medium, and high concentrations of QC samples were tested under the following test conditions: stored at an autosampler for 12 hours, stored at room temperature for 6 hours, put through three freeze/thaw cycles, and stored at -80°C for 14 days. Three QC concentrations were tested for each of the above conditions.

2.7. The Study of Pharmacokinetics {#sec2.7}
----------------------------------

Six male Sprague-Dawley rats (250 ± 5 g) were purchased from Huafukang Bioscience Co., Inc. (Beijing, China). The rats were adapted to the facility for a week. Before the experiments, rats were fasted for 12 h, although drinking water was readily accessible. *Flos Chrysanthemi* extract was dissolved in CMC-Na aqueous solution and orally administered to the animals once at 10 g/kg. Blood samples (220 *μ*L) were taken from the orbital venous plexus of rats at 0, 0.03, 0.08, 0.17, 0.25, 0.5, 1, 2, 4, 6, 8, 10, 12, and 24 h after extract administration. Blood samples were promptly centrifuged at 6000 rpm for 10 min, and plasma samples were collected. The obtained plasma was stored at -80°C until analysis. "Drug and Statistics 3.0" software (Medical College of Wannan, China) was used to calculate pharmacokinetic parameters. The animal protocol was approved by the Animal Ethics Committee of Tianjin University of Traditional Chinese Medicine (TCM-LAEC20190056).

3. Results {#sec3}
==========

3.1. LC-MS/MS Optimization {#sec3.1}
--------------------------

Various types of mobile phases were investigated for optimal separation of the 13 compounds, such as the use of acetonitrile or methanol as mobile (B) and 0.05% or 0.1% formic acid in water as mobile (A). Experimental results showed that acetonitrile (B) and 0.1% (*v*/*v*) formic acid in water (A) provided better peak shapes and reduced separation timings. Both positive and negative ion modes of the AJS ESI source were experimented for optimal mass spectrometry results. A negative ion mode showed greater signal intensity; thus, the thirteen compounds were quantitated with AJS ESI in the negative ion mode.

3.2. Sample Preparation {#sec3.2}
-----------------------

In the study, we identified two simple and efficient methods for processing plasma samples: protein precipitation and liquid-liquid extraction. The ethyl acetate liquid-liquid extraction method provided better recovery of flavonoids, but the recoveries of chlorogenic acid, cryptochlorogenic acid, and isochlorogenic acid C were poor. The effects of methanol and acetonitrile on protein precipitation were then compared, and the results demonstrated that acetonitrile precipitation produced better recovery rates.

3.3. Method Validation of Bioanalysis {#sec3.3}
-------------------------------------

### 3.3.1. Specificity {#sec3.3.1}

The respective chromatograms were compared to evaluate method specificity based on analyte retention times and the presence of interference peaks. [Figure 2](#fig2){ref-type="fig"} shows chromatograms of (a) blank plasma samples, (b) blank plasma samples spiked with analytes and IS, and (c) plasma sample collected after oral administration of *Flos Chrysanthemi* extract. Results showed consistent retention times and no interference peaks for all analytes across samples.

### 3.3.2. Linearity and LLOQ {#sec3.3.2}

Values of LLOQs and calibration curves are displayed in [Table 2](#tab2){ref-type="table"}. The range of calibration curves for tilianin and hesperidin was 1-200 ng/mL; for isochlorogenic acid C, cryptochlorogenic acid, chlorogenic acid, apigenin, acacetin, hyperoside, isoquercitrin, and apigenin 7-glucoside, it was 5-1000 ng/mL; for luteolin 7-O-glucuronide, it was 10-2000 ng/mL; and for luteolin and cynaroside, it was 20-4000 ng/mL. Results showed that the compounds exhibited good linearity in the linear range *r*^2^ \> 0.9919. LLOQs were all below 5 ng/mL, indicating high sensitivity.

### 3.3.3. Precision and Accuracy {#sec3.3.3}

The intraday and interday precision and accuracy were measured with six replicates of QC samples, with analytes set at low, medium, and high concentrations as described above. The results of the analysis are shown in [Table 3](#tab3){ref-type="table"}. Accuracy (RE) ranged from -13.0% to 14.0%, and precision (RSD) ranged from 0.4% to 12.2%, indicating that the developed method was reliable.

### 3.3.4. Recovery and Matrix Effect {#sec3.3.4}

As shown in [Table 4](#tab4){ref-type="table"}, the extraction recovery of all 13 analytes, at three different concentrations, ranged between 56.9% and 95.0%. The matrix effects on all analytes ranged between 71.6% and 109.3%. These results indicated that both the matrix effect and extraction recovery are satisfactory.

### 3.3.5. Stability {#sec3.3.5}

The stability of all 13 analytes during sample collection and processing was evaluated with the various storage conditions being tested on spiked plasma samples at three QC concentrations. As shown in [Table 5](#tab5){ref-type="table"}, the RSD of all tested samples were below 11.4%, suggesting that all 13 analytes were stable in the above four test conditions.

3.4. Pharmacokinetic Study {#sec3.4}
--------------------------

Plasma samples from rats orally administered with *Flos Chrysanthemi* extract (10.0 g/kg) were analysed with UPLC-MS/MS. Plasma concentration-time curves are shown in [Figure 3](#fig3){ref-type="fig"}, and the primary pharmacokinetic parameters of each analyte are summarized in [Table 6](#tab6){ref-type="table"}.

Five analytes, namely, acacetin, hyperoside, isoquercitrin, tilianin, and hesperidin, were detected only at the first few blood sampling points following oral administration of the *Flos Chrysanthemi* extract, which made it difficult to plot a complete pharmacokinetic curve. Hence, these 5 analytes were excluded in the following results.

As shown in [Table 6](#tab6){ref-type="table"}, *C*~max~ of cynaroside and luteolin were 2547.84 ± 1121.18 ng/mL and 2079.55 ± 307.09 ng/mL, respectively, ranking as the highest two amongst the 8 remaining analytes. In addition, AUC~(0\ −\ tn)~ of cynaroside and luteolin were larger than the other analytes, indicating a higher level of plasma exposure.

*T* ~max~ of chlorogenic acid, cryptochlorogenic acid, cynaroside, luteolin 7-O-glucuronide, apigenin 7-glucoside, isochlorogenic acid C, apigenin, and luteolin were 0.25 ± 0.00 hours, 0.61 ± 0.33 hours, 6.38 ± 3.80 hours, 0.50 ± 0.27 hours, 0.69 ± 0.49 hours, 0.40 ± 0.31 hours, 0.50 ± 0.00 hours, and 0.50 ± 0.00 hours, respectively. Results showed that besides cynaroside, the other seven compounds were rapidly absorbed into the bloodstream. Meanwhile, *T*~max~ of apigenin and luteolin were similar to the values of previous reports \[[@B15]\].

*T* ~1/2~ of chlorogenic acid and isochlorogenic acid C are 0.20 h and 0.24 h, respectively, indicating that these two compounds are eliminated shortly after oral administration. *T*~1/2~ of cynaroside, luteolin 7-O-glucuronide, cryptochlorogenic acid, apigenin 7-glucoside, apigenin, and luteolin range from 5.01 h to 13.87 h, suggesting that these compounds have a relatively longer therapeutic time, especially apigenin 7-glucoside.

4. Conclusion {#sec4}
=============

A reliable and sensitive UPLC-MS/MS method was developed to measure 13 ingredients (luteolin, cynaroside, luteolin 7-O-glucuronide, isochlorogenic acid C, chlorogenic acid, cryptochlorogenic acid, apigenin 7-glucoside, apigenin, acacetin, hyperoside, isoquercitrin, tilianin, and hesperidin) after the oral administration of *Flos Chrysanthemi* extract in rat plasma. This method offered adequate specificity, precision, recovery, and stability. In addition, the results showed that the blood concentrations of cynaroside and luteolin were higher than the other 11 analytes following oral administration of the *Flos Chrysanthemi* extract. Meanwhile, the absorption and elimination of chlorogenic acid and isochlorogenic acid C were rapid compared to other compounds. These pharmacokinetic parameters facilitate further development and clinical application for *Flos Chrysanthemi.*
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![The chemical structures of the 13 ingredients.](BMRI2020-8420409.001){#fig1}

![MRM chromatograms of hesperidin (1), isochlorogenic acid C (2), isoquercitrin (3), hyperoside (4), luteolin 7-O-glucuronide (5), cynaroside (6), tilianin (7), apigenin 7-glucoside (8), chlorogenic acid (9), cryptochlorogenic acid (10), luteolin (11), acacetin (12), apigenin (13), and IS (14). (a) Blank rat plasma chromatograms, (b) blank rat plasma samples added to chemical compounds and IS, and (c) plasma samples after oral *Flos Chrysanthemi* extract administration.](BMRI2020-8420409.002){#fig2}

![Primary concentration-time curves of isochlorogenic acid C, apigenin 7-glucoside, chlorogenic acid, luteolin 7-O-glucuronide, luteolin, apigenin, cynaroside, and cryptochlorogenic acid after oral administration of *Flos Chrysanthemi* extract (*n* = 6, mean ± SD).](BMRI2020-8420409.003){#fig3}

###### 

Mass spectra properties of 13 analytes and IS.

  Compounds                  Precursor ion (*m*/*z*)   Product ion (*m*/*z*)   Frag. (*V*)   C.E. (*V*)
  -------------------------- ------------------------- ----------------------- ------------- ------------
  Chlorogenic acid           353.1                     191.0                   98            20
  Cryptochlorogenic acid     353.1                     173.0                   108           16
  Cynaroside                 449.1                     286.9                   113           24
  Tilianin                   447.1                     285.0                   128           20
  Luteolin 7-O-glucuronide   461.1                     285.0                   141           24
  Apigenin 7-glucoside       431.1                     268.0                   189           36
  Isochlorogenic acid C      515.1                     173.0                   123           32
  Luteolin                   285.0                     133.0                   151           40
  Apigenin                   269.0                     117.0                   141           36
  Hesperidin                 609.2                     301.0                   146           28
  Isoquercitrin              463.1                     300.0                   151           32
  Hyperoside                 463.1                     270.9                   156           52
  Acacetin                   283.1                     268.0                   128           24
  Icariin (IS)               675.2                     513.1                   194           28

###### 

Calibration curves, correlation coefficients, linear ranges, and LLOQ of the 13 analytes.

  Compounds                  Calibration curves              Correlation coefficients (*r*^2^)   Linear range (ng/mL)   LLOQ (ng/mL)
  -------------------------- ------------------------------- ----------------------------------- ---------------------- --------------
  Luteolin                   *Y* = 6.422005*X* + 0.176762    0.9964                              20.0-4000.0            0.1
  Cynaroside                 *Y* = 0.047193*X* + 0.015018    0.9937                              20.0-4000.0            0.1
  Luteolin 7-O-glucuronide   *Y* = 6.507693*X* + 0.091156    0.9927                              10.0-2000.0            2.0
  Isochlorogenic acid C      *Y* = 2.288985*X* + 0.006645    0.9919                              5.0-1000.0             5.0
  Cryptochlorogenic acid     *Y* = 3.232775*X* − 0.004798    0.9990                              5.0-1000.0             5.0
  Chlorogenic acid           *Y* = 8.628364*X* + 0.060601    0.9943                              5.0-1000.0             0.2
  Apigenin                   *Y* = 8.015200*X* + 0.032229    0.9993                              5.0-1000.0             0.2
  Acacetin                   *Y* = 63.711025*X* + 1.046168   0.9984                              5.0-1000.0             0.1
  Hyperoside                 *Y* = 7.003472*X* + 0.008604    0.9953                              5.0-1000.0             0.2
  Isoquercitrin              *Y* = 14.354529*X* + 0.013019   0.9958                              5.0-1000.0             0.2
  Apigenin 7-glucoside       *Y* = 20.395291*X* + 0.169449   0.9989                              5.0-1000.0             0.1
  Tilianin                   *Y* = 53.090940*X* + 0.077200   0.9924                              1.0-200.0              0.1
  Hesperidin                 *Y* = 4.330534*X* − 0.008981    0.9975                              1.0-200.0              1.0

###### 

Precision and accuracy of 13 analytes in rat plasma (*n* = 6).

  Compounds                  Spiked concentration (ng/mL)   Intraday     Interday                                        
  -------------------------- ------------------------------ ------------ ---------- --------------- ------------ ------- ------
  Luteolin                   20                             20.0 ± 0.4   0.0        2.0             20.4 ± 0.2   2.0     1.0
  200                        187.6 ± 1.6                    -6.2         0.9        188.5 ± 2.5     -5.8         1.3     
  4000                       4083.2 ± 46.1                  2.1          1.1        4110.2 ± 65.5   2.8          1.6     
  Cynaroside                 20                             20.9 ± 0.9   4.5        4.3             20.5 ± 0.8   2.5     3.9
  200                        208.1 ± 2.1                    4.1          1.0        201.0 ± 0.9     0.5          0.4     
  4000                       3903.5 ± 58.1                  -2.4         1.5        3921.2 ± 39.8   -2.0         1.0     
  Luteolin 7-O-glucuronide   10                             9.0 ± 0.5    -10.0      5.6             8.9 ± 0.4    -10.0   4.5
  100                        88.5 ± 0.6                     -11.5        0.7        89.1 ± 2.1      -10.9        2.4     
  2000                       1840.1 ± 27.1                  -8.0         1.5        1848.2 ± 36.6   -7.6         2.0     
  Isochlorogenic acid C      5                              4.6 ± 0.2    -8.0       4.3             4.9 ± 0.3    -2.0    6.1
  50                         44.4 ± 1.0                     -11.2        2.3        45.1 ± 1.3      -9.8         2.9     
  1000                       1019.6 ± 26.6                  2.0          2.6        1019.9 ± 34.6   2.0          3.4     
  Cryptochlorogenic acid     5                              5.0 ± 0.2    0.0        4.0             5.0 ± 0.1    0.0     2.0
  50                         44.0 ± 0.9                     -12.0        2.0        44.2 ± 0.8      -11.6        1.8     
  1000                       1031.4 ± 24.1                  3.1          2.3        1031.8 ± 25.0   3.2          2.4     
  Chlorogenic acid           5                              4.9 ± 0.3    -2.0       6.1             5.0 ± 0.3    0.0     6.0
  50                         46.7 ± 2.2                     -6.6         4.7        47.3 ± 2.2      -5.4         4.7     
  1000                       1057.8 ± 21.6                  5.8          2.0        1074.5 ± 27.7   7.5          2.6     
  Apigenin                   5                              5.6 ± 0.1    12.0       1.8             5.6 ± 0.1    12.0    1.8
  50                         44.5 ± 1.2                     -11.0        2.7        45.3 ± 1.2      -9.4         2.6     
  1000                       1043.9 ± 35.9                  4.4          3.4        1048.8 ± 30.5   4.9          2.9     
  Acacetin                   5                              5.5 ± 0.2    10.0       3.6             4.9 ± 0.6    -2.0    12.2
  50                         45.1 ± 0.7                     -9.8         1.6        45.3 ± 1.1      -9.4         2.4     
  1000                       1038.1 ± 26.0                  3.8          2.5        1044.8 ± 23.6   4.5          2.3     
  Hyperoside                 5                              4.6 ± 0.1    -8.0       2.2             4.7 ± 0.2    -6.0    4.3
  50                         45.8 ± 1.1                     -8.4         2.4        45.9 ± 1.3      -8.2         2.8     
  1000                       1019.7 ± 46.4                  2.0          4.6        1032.2 ± 40.9   3.2          4.0     
  Isoquercitrin              5                              4.8 ± 0.2    -4.0       4.2             4.9 ± 0.2    -2.0    4.1
  50                         44.8 ± 0.5                     -10.4        1.1        45.5 ± 1.1      -9.0         2.4     
  1000                       944.6 ± 41.8                   -5.5         4.4        1000.7 ± 30.1   0.1          3.0     
  Apigenin 7-glucoside       5                              5.7 ± 0.1    14.0       1.8             5.7 ± 0.1    14.0    1.8
  50                         45.6 ± 1.0                     -8.8         2.2        45.5 ± 1.0      -9.0         2.2     
  1000                       1078.0 ± 26.9                  7.8          2.5        1070.0 ± 34.2   7.0          3.2     
  Tilianin                   1                              0.9 ± 0.1    -10.0      11.1            0.9 ± 0.1    -10.0   11.1
  10                         9.7 ± 0.4                      -3.0         4.1        9.8 ± 0.4       -2.0         4.1     
  200                        201.7 ± 2.5                    0.8          1.2        200.7 ± 3.9     0.3          1.9     
  Hesperidin                 1                              1.1 ± 0.1    10.0       9.1             1.1 ± 0.1    10.0    9.1
  10                         8.7 ± 0.2                      -13.0        2.3        8.9 ± 0.2       -11.0        2.2     
  200                        223.6 ± 2.0                    11.8         0.9        222.3 ± 2.0     11.2         0.9     

###### 

Extraction recoveries and matrix effects of the analytes (*n* = 6).

  Compounds                  Spiked concentration (ng/mL)   Extraction recovery (%)   RSD (%)        Matrix effect (%)   RSD (%)
  -------------------------- ------------------------------ ------------------------- -------------- ------------------- ---------
  Luteolin                   20                             91.0 ± 2.0                2.2            109.2 ± 3.6         3.3
  200                        80.7 ± 10.5                    13.0                      96.6 ± 7.0     7.2                 
  4000                       78.9 ± 5.5                     7.0                       89.8 ± 2.8     3.1                 
  Cynaroside                 20                             94.9 ± 11.1               11.7           101.7 ± 2.6         2.6
  200                        73.8 ± 7.6                     10.3                      109.3 ± 8.4    7.7                 
  4000                       85.8 ± 3.0                     3.5                       97.6 ± 1.9     1.9                 
  Luteolin 7-O-glucuronide   10                             76.5 ± 8.3                10.8           109.1 ± 2.6         2.4
  100                        69.2 ± 2.0                     2.9                       100.4 ± 1.2    1.2                 
  2000                       57.4 ± 4.7                     8.2                       101.8 ± 6.3    6.2                 
  Isochlorogenic acid C      5                              77.3 ± 11.2               14.5           95.4 ± 13.4         14.0
  50                         72.7 ± 4.4                     6.1                       106.4 ± 6.1    5.7                 
  1000                       75.6 ± 3.2                     4.2                       90.6 ± 4.6     5.1                 
  Cryptochlorogenic acid     5                              69.8 ± 9.5                13.6           95.5 ± 3.2          3.4
  50                         61.2 ± 4.1                     6.7                       107.5 ± 8.4    7.8                 
  1000                       75.3 ± 1.1                     1.5                       109.3 ± 3.1    2.6                 
  Chlorogenic acid           5                              74.3 ± 4.1                5.5            86.6 ± 4.3          5.0
  50                         84.2 ± 7.6                     9.0                       82.0 ± 11.5    14.0                
  1000                       69.6 ± 4.4                     6.3                       81.1 ± 2.8     3.5                 
  Apigenin                   5                              80.9 ± 4.9                6.1            99.7 ± 6.1          6.1
  50                         95.0 ± 4.5                     4.7                       71.6 ± 8.1     11.3                
  1000                       74.3 ± 5.6                     7.5                       87.2 ± 2.3     2.6                 
  Acacetin                   5                              83.3 ± 8.4                10.1           104.0 ± 4.5         4.3
  50                         74.8 ± 6.6                     8.8                       111.6 ± 10.1   9.1                 
  1000                       78.0 ± 5.6                     7.2                       85.9 ± 1.6     1.9                 
  Hyperoside                 5                              63.4 ± 4.5                7.1            101.3 ± 4.9         4.8
  50                         70.7 ± 8.8                     12.4                      81.0 ± 10.7    13.2                
  1000                       67.6 ± 4.2                     6.2                       85.0 ± 2.4     2.8                 
  Isoquercitrin              5                              58.5 ± 4.3                7.4            97.2 ± 3.4          3.5
  50                         56.9 ± 1.7                     3.0                       92.7 ± 9.9     10.7                
  1000                       67.6 ± 4.1                     6.1                       85.0 ± 2.6     3.1                 
  Apigenin 7-glucoside       5                              86.7 ± 7.6                8.8            104.4 ± 4.4         4.2
  50                         81.5 ± 9.4                     11.5                      91.4 ± 7.0     7.7                 
  1000                       74.9 ± 5.6                     7.5                       85.4 ± 3.0     3.5                 
  Tilianin                   1                              75.3 ± 10.8               14.3           104.1 ± 3.3         3.2
  10                         72.2 ± 7.4                     10.2                      100.9 ± 11.8   11.7                
  200                        84.6 ± 3.9                     4.6                       95.6 ± 1.7     1.8                 
  Hesperidin                 1                              86.2 ± 11.2               13.0           103.1 ± 9.6         9.3
  10                         84.5 ± 6.1                     7.2                       89.3 ± 10.4    11.6                
  200                        75.3 ± 5.6                     7.4                       84.6 ± 1.4     1.7                 

###### 

Stability of 13 analytes in rat plasma (*n* = 6).

  Compounds                  Spiked concentration (ng/mL)   Room temperature for 6 h   Three freeze-thaw cycles   Autosampler for 12 h   -80°C for 14 days                                              
  -------------------------- ------------------------------ -------------------------- -------------------------- ---------------------- ------------------- ------------ ---------------- ------------ ------
  Luteolin                   20                             20.3 ± 0.3                 1.5                        23.2 ± 0.7             3.0                 21.3 ± 0.4   1.9              17.4 ± 0.3   1.7
  200                        193.5 ± 3.3                    1.7                        223.7 ± 1.5                0.7                    181.7 ± 0.8         0.4          195.1 ± 2.6      1.3          
  4000                       4419.0 ± 9.2                   0.2                        4475.1 ± 11.8              0.3                    3656.3 ± 33.7       0.9          4195.2 ± 15.1    0.4          
  Cynaroside                 20                             20.6 ± 0.9                 4.4                        22.6 ± 1.0             4.4                 20.0 ± 0.2   1.0              21.1 ± 0.8   3.8
  200                        182.4 ± 0.6                    0.3                        219.8 ± 1.0                0.5                    203.4 ± 6.1         3.0          205.0 ± 4.0      2.0          
  4000                       4360.1 ± 32.4                  0.7                        4152.9 ± 34.1              0.8                    4158.6 ± 15.3       0.4          4060.3 ± 121.9   3.0          
  Luteolin 7-O-glucuronide   10                             10.9 ± 0.8                 7.3                        11.1 ± 0.1             0.9                 9.6 ± 0.3    3.1              8.8 ± 0.2    2.3
  100                        110.9 ± 1.2                    1.1                        112.6 ± 0.5                0.4                    90.7 ± 0.4          0.4          99.7 ± 0.3       0.3          
  2000                       2214.4 ± 17.9                  0.8                        2225.7 ± 9.3               0.4                    1960.1 ± 38.5       2.0          1930.7 ± 22.5    1.2          
  Isochlorogenic acid C      5                              5.2 ± 0.2                  3.8                        5.9 ± 0.1              1.7                 4.6 ± 0.4    8.7              5.6 ± 0.1    1.8
  50                         48.1 ± 0.8                     1.7                        55.3 ± 0.4                 0.7                    45.1 ± 0.6          1.3          43.3 ± 0.3       0.7          
  1000                       1049.2 ± 32.0                  3.0                        1052.4 ± 38.4              3.6                    1047.3 ± 12.4       1.2          1080.3 ± 37.8    3.5          
  Cryptochlorogenic acid     5                              5.3 ± 0.1                  1.9                        5.9 ± 0.1              1.7                 5.0 ± 0.2    4.0              5.2 ± 0.2    3.8
  50                         49.1 ± 1.5                     3.1                        54.1 ± 0.3                 0.6                    44.5 ± 1.3          2.9          46.7 ± 1.4       3.0          
  1000                       1012.9 ± 11.1                  1.1                        1122.8 ± 6.8               0.6                    1069.3 ± 16.2       1.5          1075.7 ± 52.9    4.9          
  Chlorogenic acid           5                              5.8 ± 0.1                  1.7                        5.8 ± 0.1              1.7                 5.1 ± 0.1    2.0              5.2 ± 0.1    1.9
  50                         49.7 ± 2.3                     4.6                        54.7 ± 0.4                 0.7                    43.5 ± 0.7          1.6          44.4 ± 0.3       0.7          
  1000                       1079.2 ± 8.3                   0.8                        1123.5 ± 7.3               0.6                    1084.8 ± 13.6       1.3          1117.1 ± 2.0     0.2          
  Apigenin                   5                              4.9 ± 0.1                  2.0                        5.7 ± 0.1              1.8                 5.4 ± 0.2    3.7              5.2 ± 0.1    1.9
  50                         49.3 ± 1.1                     2.2                        50.5 ± 0.4                 0.8                    45.8 ± 1.3          2.8          49.3 ± 1.9       3.9          
  1000                       1112.4 ± 11.7                  1.1                        1086.4 ± 17.6              1.6                    987.0 ± 11.4        1.2          1063.8 ± 62.8    5.9          
  Acacetin                   5                              4.6 ± 0.1                  2.2                        5.8 ± 0.1              1.7                 5.3 ± 0.1    1.9              4.5 ± 0.1    2.2
  50                         50.3 ± 0.8                     1.6                        50.2 ± 5.7                 11.4                   47.8 ± 0.7          1.5          50.5 ± 0.7       1.4          
  1000                       1126.2 ± 9.5                   0.8                        1032.7 ± 5.6               0.5                    1030.3 ± 4.9        0.5          977.4 ± 57.9     5.9          
  Hyperoside                 5                              4.4 ± 0.1                  2.3                        5.7 ± 0.1              1.8                 3.9 ± 0.1    2.6              4.8 ± 0.2    4.2
  50                         48.7 ± 1.9                     3.9                        54.5 ± 2.1                 3.9                    41.8 ± 1.4          3.3          50.3 ± 1.8       3.6          
  1000                       1009.6 + 19.9                  2.0                        1110.2 ± 4.5               0.4                    803.4 ± 2.5         0.3          997.8 ± 19.4     1.9          
  Isoquercitrin              5                              4.7 ± 0.2                  4.3                        5.6 ± 0.1              1.8                 4.0 ± 0.2    5.0              4.5 ± 0.1    2.2
  50                         49.0 ± 1.2                     2.4                        54.5 ± 0.8                 1.5                    41.6 ± 0.5          1.2          50.7 ± 2.1       4.1          
  1000                       1039.7 ± 20.6                  2.0                        1110.5 ± 21.8              2.0                    1039.7 ± 20.6       2.0          1006.3 ± 30.5    3.0          
  Apigenin 7-glucoside       5                              5.9 ± 0.1                  1.7                        5.6 ± 0.4              7.1                 4.3 ± 0.1    2.3              5.1 ± 0.2    3.9
  50                         50.5 ± 1.0                     2.0                        53.7 ± 0.6                 1.1                    44.5 ± 0.7          1.6          51.1 ± 0.4       0.8          
  1000                       1086.7 ± 12.9                  1.2                        1112.8 ± 7.2               0.6                    1077.6 ± 9.6        0.9          1108.3 ± 25.6    2.3          
  Tilianin                   1                              1.1 ± 0.1                  9.1                        1.0 ± 0.1              10.0                0.9 ± 0.1    11.1             0.9 ± 0.1    11.1
  10                         9.9 ± 0.3                      3.0                        11.3 ± 0.2                 1.8                    9.3 ± 0.1           1.1          10.2 ± 0.2       2.0          
  200                        226.4 ± 0.2                    0.1                        209.6 ± 0.3                0.1                    179.0 ± 1.2         0.7          188.6 ± 0.9      0.5          
  Hesperidin                 1                              1.1 ± 0.1                  9.1                        1.1 ± 0.1              9.1                 1.0 ± 0.1    10.0             1.1 ± 0.1    9.1
  10                         10.2 ± 0.4                     3.9                        10.0 ± 0.1                 1.0                    8.8 ± 0.1           1.1          9.5 ± 0.2        2.1          
  200                        213.7 ± 2.1                    1.0                        218.3 ± 0.7                0.3                    222.7 ± 2.0         0.9          209.5 ± 2.3      1.1          

###### 

Pharmacokinetic parameters of 8 analytes after oral administration of *Flos Chrysanthemi* extract (*n* = 6).

  Compounds                  *T* ~max~ (h)   *C* ~max~ (ng/mL)   *T* ~1/2~ (h)   Ke (1/h)      AUC~(0\ −\ tn)~ (h·ng/mL)   AUC~(0\ −\ ∞)~ (h·ng/mL)
  -------------------------- --------------- ------------------- --------------- ------------- --------------------------- --------------------------
  Chlorogenic acid           0.25 ± 0.00     194.41 ± 56.36      0.20 ± 0.17     4.03 ± 0.90   425.83 ± 139.21             494.42 ± 204.82
  Cryptochlorogenic acid     0.61 ± 0.33     89.36 ± 45.31       6.90 ± 3.40     0.12 ± 0.04   318.79 ± 97.33              431.13 ± 196.93
  Cynaroside                 6.38 ± 3.80     2547.84 ± 1121.18   5.01 ± 4.44     0.28 ± 0.24   19064.87 ± 19942.21         19092.57 ± 19960.87
  Luteolin 7-O-glucuronide   0.50 ± 0.27     749.25 ± 195.04     6.17 ± 1.43     0.12 ± 0.03   6448.10 ± 1807.31           6731.89 ± 2276.56
  Apigenin 7-glucoside       0.69 ± 0.49     96.43 ± 24.75       13.87 ± 10.15   0.25 ± 0.20   1321.88 ± 488.77            1473.6352 ± 614.27
  Isochlorogenic acid C      0.40 ± 0.31     101.23 ± 73.33      0.24 ± 0.22     4.69 ± 2.04   309.13 ± 148.61             404.53 ± 228.04
  Apigenin                   0.50 ± 0.00     301.81 ± 87.13      11.11 ± 7.10    0.09 ± 0.05   2903.87 ± 251.44            3088.95 ± 447.45
  Luteolin                   0.50 ± 0.00     2079.55 ± 307.09    8.89 ± 4.01     0.10 ± 0.05   24237.94 ± 2113.55          25094.35 ± 2232.12

[^1]: Academic Editor: Yun-Peng Chao
